IAIM
ALDX icon

International Assets Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

International Assets Investment Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.3K Sell
36,750
-610
-2% -$1.05K 0.01% 1133
2026
Q1 		$62.8K Sell
37,360
-10,115
-21% -$44.3K ﹤0.01% 1150
2025
Q4 		$246K Sell
47,475
-1,165
-2% -$5.99K 0.02% 729
2025
Q3 		$191K Hold
48,640
– – 0.02% 769
2025
Q2 		$186K Hold
48,640
– – 0.02% 776
2025
Q1 		$280K Sell
48,640
-11,110
-19% -$65.7K 0.02% 594
2024
Q4 		$312K Buy
59,750
+6,450
+12% +$33.1K 0.03% 555
2024
Q3 		$287K Sell
53,300
-4,500
-8% -$21.4K 0.02% 480
2024
Q2 		$191K Sell
57,800
-2,500
-4% -$9.79K 0.02% 732
2024
Q1 		$197K Buy
60,300
+1,800
+3% +$5.92K 0.02% 686
2023
Q4 		$205K Buy
58,500
+9,518
+19% +$29.4K 0.03% 628
2023
Q3 		$299K Buy
48,982
+695
+1% +$5.16K 0.04% 374
2023
Q2 		$405K Sell
48,287
-19,105
-28% -$188K 0.05% 316
2023
Q1 		$669K Buy
67,392
+4,585
+7% +$32.4K 0.1% 210
2022
Q4 		$437K Buy
62,807
+3,530
+6% +$20.2K 0.05% 376
2022
Q3 		$317K Sell
59,277
-598
-1% -$3.59K 0.07% 271
2022
Q2 		$239K Buy
59,875
+2,750
+5% +$9.46K 0.02% 344
2022
Q1 		$254K Buy
57,125
+6,800
+14% +$27.1K 0.05% 361
2021
Q4 		$201K Buy
50,325
+8,125
+19% +$62K 0.04% 463
2021
Q3 		$371K Buy
42,200
+14,925
+55% +$137K 0.07% 293
2021
Q2 		$309K Sell
27,275
-10,080
-27% -$121K 0.06% 329
2021
Q1 		$306K Buy
37,355
+10,040
+37% +$116K 0.03% 431
2020
Q4 		$187K Buy
+27,315
New +$192K 0.03% 390

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

International Assets Investment Management's ALDX Position: Q2 2026 in Review

International Assets Investment Management reduced its Aldeyra Therapeutics (ALDX) stake by 1.6% in Q2 2026, selling an estimated $1.05K and leaving 36,750 shares worth $89.3K. The position accounts for 0.01% of the portfolio, ranked #1133.

International Assets Investment Management first reported a position in ALDX in Q4 2020 and has held it in 23 quarters since. The position peaked at $669K in Q1 2023. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • International Assets Investment Management held 36,750 shares of Aldeyra Therapeutics worth $89.3K as of Q2 2026.
  • International Assets Investment Management sold 610 Aldeyra Therapeutics shares in Q2 2026, an estimated $1.05K.
  • Aldeyra Therapeutics made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1133 holding.
  • International Assets Investment Management first reported a position in Aldeyra Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • International Assets Investment Management's Aldeyra Therapeutics position peaked at $669K in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.